BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21874584)

  • 1. VP22 enhances the expression of glucocerebrosidase in human Gaucher II fibroblast cells mediated by lentiviral vectors.
    Jin GS; Zhu GD; Zhao ZG; Liu FS
    Clin Exp Med; 2012 Sep; 12(3):135-43. PubMed ID: 21874584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and secretion of human glucocerebrosidase mediated by recombinant lentivirus vectors in vitro and in vivo: implications for gene therapy of Gaucher disease.
    Kim EY; Hong YB; Lai Z; Kim HJ; Cho YH; Brady RO; Jung SC
    Biochem Biophys Res Commun; 2004 May; 318(2):381-90. PubMed ID: 15120612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VP22 and cytosine deaminase fusion gene modified tissue-engineered neural stem cells for glioma therapy.
    Jin G; Zhou Y; Chai Q; Zhu G; Xu F; Liu F
    J Cancer Res Clin Oncol; 2013 Mar; 139(3):475-83. PubMed ID: 23180018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retroviral-mediated transfer of the human glucocerebrosidase gene into cultured Gaucher bone marrow.
    Nolta JA; Yu XJ; Bahner I; Kohn DB
    J Clin Invest; 1992 Aug; 90(2):342-8. PubMed ID: 1379609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bicistronic therapeutic retroviral vector enables sorting of transduced CD34+ cells and corrects the enzyme deficiency in cells from Gaucher patients.
    Medin JA; Migita M; Pawliuk R; Jacobson S; Amiri M; Kluepfel-Stahl S; Brady RO; Humphries RK; Karlsson S
    Blood; 1996 Mar; 87(5):1754-62. PubMed ID: 8634421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term expression of the human glucocerebrosidase gene in vivo after transplantation of bone-marrow-derived cells transformed with a lentivirus vector.
    Kim EY; Hong YB; Lai Z; Cho YH; Brady RO; Jung SC
    J Gene Med; 2005 Jul; 7(7):878-87. PubMed ID: 15712335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of transduced CD34+ progenitors and enzymatic correction of cells from Gaucher patients, with bicistronic vectors.
    Migita M; Medin JA; Pawliuk R; Jacobson S; Nagle JW; Anderson S; Amiri M; Humphries RK; Karlsson S
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12075-9. PubMed ID: 8618847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete restoration of glucocerebrosidase deficiency in Gaucher fibroblasts using a bicistronic MDR retrovirus and a new selection strategy.
    Aran JM; Licht T; Gottesman MM; Pastan I
    Hum Gene Ther; 1996 Nov; 7(17):2165-75. PubMed ID: 8934230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intercellular delivery of a herpes simplex virus VP22 fusion protein from cells infected with lentiviral vectors.
    Lai Z; Han I; Zirzow G; Brady RO; Reiser J
    Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11297-302. PubMed ID: 11027330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction of the enzyme deficiency in hematopoietic cells of Gaucher patients using a clinically acceptable retroviral supernatant transduction protocol.
    Xu L; Stahl SK; Dave HP; Schiffmann R; Correll PH; Kessler S; Karlsson S
    Exp Hematol; 1994 Feb; 22(2):223-30. PubMed ID: 8299741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence of an autologous marrow stromal cell layer increases glucocerebrosidase gene transduction of long-term culture initiating cells (LTCICs) from the bone marrow of a patient with Gaucher disease.
    Wells S; Malik P; Pensiero M; Kohn DB; Nolta JA
    Gene Ther; 1995 Oct; 2(8):512-20. PubMed ID: 8593601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward gene therapy for Gaucher disease.
    Kohn DB; Nolta JA; Weinthal J; Bahner I; Yu XJ; Lilley J; Crooks GM
    Hum Gene Ther; 1991; 2(2):101-5. PubMed ID: 1911928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentiviral gene therapy using cellular promoters cures type 1 Gaucher disease in mice.
    Dahl M; Doyle A; Olsson K; MÃ¥nsson JE; Marques ARA; Mirzaian M; Aerts JM; Ehinger M; Rothe M; Modlich U; Schambach A; Karlsson S
    Mol Ther; 2015 May; 23(5):835-844. PubMed ID: 25655314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple and efficient purification of transduced cells by using green fluorescent protein gene as a selection marker.
    Shimizu T; Ando K; Kimura M; Miyatake H; Inokuchi S; Takakura I; Migita M; Shimada T; Kato S
    Acta Paediatr Jpn; 1998 Dec; 40(6):586-92. PubMed ID: 9893295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus VP22 enhances adenovirus-mediated microdystrophin gene transfer to skeletal muscles in dystrophin-deficient (mdx) mice.
    Xiong F; Xiao S; Peng F; Zheng H; Yu M; Ruan Y; Li W; Shang Y; Zhao C; Zhou W; Chen H; Chamberlain JS; Fang L; Zhang C
    Hum Gene Ther; 2007 Jun; 18(6):490-501. PubMed ID: 17550336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction of glucocerebrosidase deficiency after retroviral-mediated gene transfer into hematopoietic progenitor cells from patients with Gaucher disease.
    Fink JK; Correll PH; Perry LK; Brady RO; Karlsson S
    Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2334-8. PubMed ID: 2315324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced effect of microdystrophin gene transfection by HSV-VP22 mediated intercellular protein transport.
    Xiong F; Xiao S; Yu M; Li W; Zheng H; Shang Y; Peng F; Zhao C; Zhou W; Chen H; Fang L; Chamberlain JS; Zhang C
    BMC Neurosci; 2007 Jul; 8():50. PubMed ID: 17617925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation.
    Dunbar CE; Kohn DB; Schiffmann R; Barton NW; Nolta JA; Esplin JA; Pensiero M; Long Z; Lockey C; Emmons RV; Csik S; Leitman S; Krebs CB; Carter C; Brady RO; Karlsson S
    Hum Gene Ther; 1998 Nov; 9(17):2629-40. PubMed ID: 9853529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VP22-mediated intercellular transport correlates with enhanced biological activity of MybEngrailed but not (HSV-I) thymidine kinase fusion proteins in primary vascular cells following non-viral transfection.
    Sheridan PJ; Lawrie A; Crossman DC; Holt CM; Newman CM
    J Gene Med; 2005 Mar; 7(3):375-85. PubMed ID: 15543525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of miRNAs that modulate glucocerebrosidase activity in Gaucher disease cells.
    Siebert M; Westbroek W; Chen YC; Moaven N; Li Y; Velayati A; Saraiva-Pereira ML; Martin SE; Sidransky E
    RNA Biol; 2014; 11(10):1291-300. PubMed ID: 25584808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.